This scenario would be a near certainty under Mr. Caracciolo's leadership. His record is a proof of this. But Mr. Pourhassan has shown a remarkable ability to finance the company with minimum of dilution. It is in main part because of his business skills LL has made an astonishing progress in the last two years. So I don't see any reason why he won't be able to finance our progress, especially after such spectacular results for a number of LL indications.